CD4 and graft versus host disease: In vitro, NGO directly suppressed T‐cell proliferation, reduced Th1 differentiation (as indicated by decreased IFN‐γ‐producing CD4+ T cells), and promoted Treg expansion, which is a key mechanism for attenuating GVHD.